Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine

(Daniel Schludi, Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19.

Today’s contract with CureVac enlarges the already broad portfolio of vaccines to be produced in Europe, including the contracts signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV and BioNtech-Pfizer, and the successful exploratory talks with Moderna. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective. Member States can also decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said:  “A few days after our contract with BioNTech and Pfizer, I am delighted to announce a new agreement with a promising European company. The Commission has secured to date at least 1.2 billion doses and fulfils its commitment to ensuring equitable access to safe, effective and affordable vaccines not only for EU citizens but also for the world’s poorest and most vulnerable people. Most of these vaccine candidates are in an advanced phase of clinical trials, hopefully authorisation will confirm these positive results, after which they will be quickly deployed and help us in overcoming the pandemic.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “With growing numbers of COVID patients across the EU, a safe and effective vaccine is more crucial than ever in putting behind us the pandemic. With this fifth vaccine advance purchase agreement, we are further expanding the possibilities that EU citizens and our economies can soon safely return to normality. It is yet another milestone in our EU Vaccines Strategy, and evidence of the benefits of working together in a genuine European Health Union.”

CureVac, a European company based in Germany, signed a €75 million loan agreement with the European Investment Bank on 6 July for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against COVID-19. CureVac is pioneering the development of a completely new class of vaccines based on messenger RNA (mRNA), transported into cells by lipid nanoparticles. The vaccine platform has been developed over the last decade. The basic principle is the use of this molecule as a data carrier for information, with the help of which the body itself can produce its own active substances to combat various diseases.

The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply the whole of the EU.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies.

The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response. On 12 November, the European Union announced the contribution of an additional €100 million in grant funding to support the COVAX Facility.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Central Africa Republic: Violence drives thousands of refugees into neighbouring DR Congo, says UN agency

Local innovation, international impact: SMEs and the ITU Telecom World Awards

Remarks by H.E. Ambassador Zhang Ming At the Reception in Celebration of the 70th Anniversary of the Founding of the People’s Republic of China

ECB ready to counter the rise of the euro?

How can entrepreneurship tackle the migration crisis in the EU?

Cutting money transfer fees could unlock $15bn for developing countries. Here’s how

EU-US trade war: Will Trump take advantage of WTO’s decision leading to ominous economic growth?

MEPs unanimously condemn recent terrorist attacks in France and Austria

How technology is leading us to new climate change solutions

Is a full course lunch, a new Commissioner and 2 million anti-TTIP citizens what you would call a “Fresh Start”?

Multilateralism more vital than ever, as World War centenary looms: Security Council

The Ukrainian crisis to destabilize Europe and the world for a long time

Kids who live in the countryside have better motor skills, a study in Finland has found

Conflict prevention, mediation: among ‘most important tools’ to reduce human suffering, Guterres tells Security Council

How global food safety protects the planet and begins on the farm

Preventing and resolving conflicts must form ‘backbone’ of collective efforts – UN chief

Who should pay for workers to be reskilled?

The British “nonsense”, the relaxed Commissioner and the TTIP “chiaroscuro” at this week’s Council

Women’s work faces the greatest risk of automation, says new research

EU finally agrees on target for 40% greenhouse emission cuts ahead of Paris climate talks

Ambassador Zhang wishes from Brussels great success and prosperity for the China-EU relations in the Year of the Dog

Children of ISIL terrorists likely held in ‘secret detention facilities’, UN human rights office warns

FIFA and UN kick off healthy living campaign, to harness global game’s ‘huge potential’

UN Security Council hails ‘courage’ of Afghan voters

EU free-trade agreements with Canada and US: imagine the fallout if put to national referendums

Industrial policy: recommendations to support Europe’s leadership in six strategic business areas

Zuckerberg, a paella, and the mighty EU questionnaires that would stop Whatsapp acquisition by Facebook?

This massive project in Spain is the latest milestone in Europe’s solar power boom

Why AI will make healthcare personal

Predicting two more years of economic stagnation

‘Provocative actions and inflammatory rhetoric’ destabilizing Middle East, warns top UN official

Ebola not an international ‘health emergency’ but risks spreading across DR Congo border, warns UN health agency

ECB to play down IMF’s alarms for deflation danger in the EU

‘Highly explosive’ escalation of conflict and displacement across Syria’s Idlib, says top UN official

Where are the world’s nuclear weapons?

Here are 10 of the most urgent health challenges we’ll face in the 2020s, according to WHO

UN agencies launch emergency plan for millions of Venezuelan refugees and migrants

UN’s Bachelet rejects Sri Lankan official’s ‘spin’ on Human Rights Council encounter, urges reforms

Coldplay stop touring to save the world: is pop music going sustainable?

MWC 2016 LIVE: GTI shifts to phase two – 5G – after hitting milestones

Here’s how we get businesses to harmonize on climate change

Acute food insecurity ‘far too high’ UN agency warns, as 113 million go hungry

Commission refers Denmark to the Court for failing to fulfil its obligations in relation to the name “Feta”

Infringement – Commission takes Italy to Court for its incomplete regime of access to genetic resources

UN summits to urge ‘ambition and action’ on climate change, sustainable development: Guterres

Climate change is a disruptor. Here’s how to harness it for innovation

A dangerously hot climate, simmering political tensions: ‘This is not the summer of our youth,’ UN chief warns

Scientists studied microbes feeding on Antarctica’s first methane leak – here’s what they found

How is COVID-19 affecting claims handling for hurricane damage?

Here’s why leaders need to care about mental health

MWC 2016 Live: Roshan CEO opens up on Afghanistan challenges

Who really cares about the 26.2 million of EU jobless?

Switzerland to favour EU citizens in immigration quotas as the risk of a new referendum looms

Syria: WHO appeals for funding to sustain critical health care for millions trapped by conflict

Chronic illnesses: UN stands up to stop 41 million avoidable deaths per year

The Great Reset requires FinTechs – and FinTechs require a common approach to cybersecurity

Renewal of cross-border aid operation critical to northern Syria: UN relief chief

Why Africa must be ready to take the quantum leap

Violence against women a barrier to peaceful future for all

This is why attractive cities do better economically

More Stings?

Advertising

Trackbacks

  1. […] Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine – […]

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s